RxDoctor Payments Data

Stephen Ulrich, MD

Family Medicine · New Lexington, OHNPI 1881670792

Payments from drug & device makers

$5,507in general payments, 2019–2025

Across 332 payments — averaging $16.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • AstraZeneca$1K
  • Amgen$474
  • Novo Nordisk$175
  • Otsuka America Pharmaceutical, Inc.$166
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$150
  • plus $2K from 37 others

What the payments were for

  • Food & beverage$5,42198%
  • Education$862%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,507 in reported general payments places this provider in the 85th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$126
Medicare patients
14
Services billed
30

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide75$88,828
FarxigaDapagliflozin Propanediol66$72,453
JardianceEmpagliflozin38$56,031
MounjaroTirzepatide27$28,007
XareltoRivaroxaban39$26,937
EliquisApixaban37$24,527
LinzessLinaclotide18$22,858
TrulicityDulaglutide16$22,059
JanuviaSitagliptin Phosphate13$16,261
TrintellixVortioxetine Hydrobromide18$11,919
Diazepam41$10,824
Oxycodone Hcl262$5,220
Fentanyl25$3,157
Albuterol Sulfate HfaAlbuterol Sulfate86$2,718
Enoxaparin Sodium12$2,296

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$175$88,82875 claims
AstraZenecaFarxiga$1,288$72,45366 claims
Boehringer IngelheimJardiance$134$56,03138 claims
Lilly USA, LLCMounjaro, Trulicity$75$50,06643 claims
Johnson & JohnsonXarelto$145$26,93739 claims
PfizerEliquis$123$24,52737 claims
AbbVieLinzess$1,354$22,85818 claims
MerckJanuvia$103$16,26113 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$141$11,91918 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in New Lexington

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →